These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5089893)

  • 1. Abnormalities of the physiology of copper in Wilson's disease. II. The internal kinetics of copper.
    O'Reilly S; Pollycove M; Tono M; Herradora L
    Arch Neurol; 1971 Jun; 24(6):481-8. PubMed ID: 5089893
    [No Abstract]   [Full Text] [Related]  

  • 2. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu and 64 Cu.
    Strickland GT; Beckner WM; Leu ML
    Clin Sci; 1972 Nov; 43(5):617-25. PubMed ID: 5083937
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiocopper in diagnosing liver disease.
    Sternlieb I; Scheinberg IH
    Semin Nucl Med; 1972 Apr; 2(2):176-88. PubMed ID: 5025253
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease.
    Vierling JM; Shrager R; Rumble WF; Aamodt R; Berman MD; Jones EA
    Gastroenterology; 1978 Apr; 74(4):652-60. PubMed ID: 631501
    [No Abstract]   [Full Text] [Related]  

  • 9. Copper kinetics in liver disease.
    Smallwood RA; McIlveen B; Rosenoer VM; Sherlock S
    Gut; 1971 Feb; 12(2):139-44. PubMed ID: 5548560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract]   [Full Text] [Related]  

  • 11. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and erythrocyte copper, zinc, manganese and magnesium concentrations in Wilson's disease.
    Goto I; Kawano Y; Tsuchiya T; Tamagawa Y; Kuroiwa Y
    Clin Neurol Neurosurg; 1986; 88(3):193-6. PubMed ID: 3780108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 16. A mathematical model for copper metabolism and its relation to Wilson's disease.
    Hazelrig JB; Owen CA; Ackerman E
    Am J Physiol; 1966 Nov; 211(5):1075-81. PubMed ID: 5924028
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic pathways of red blood cell copper in normal humans and in Wilson's disease.
    Neumann PZ; Silverberg M
    Nature; 1967 Feb; 213(5078):775-9. PubMed ID: 6031801
    [No Abstract]   [Full Text] [Related]  

  • 18. Copper dynamics in Wilson's disease.
    Osborn SB; Walshe JM; Williams R
    Ann Biol Clin (Paris); 1972; 30(4):391-6. PubMed ID: 5082973
    [No Abstract]   [Full Text] [Related]  

  • 19. Wilson's disease: identification of an abnormal copper-binding protein.
    Evans GW; Bubois RS; Hambidge KM
    Science; 1973 Sep; 181(4105):1175-6. PubMed ID: 4726442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.